Oxybutynin for Post-surgical Bladder Pain and Urgency
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age4-8
SponsorUniversity of California, Davis
About this trial
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Eligibility criteria
Qualifiers
Patients who will undergo bladder surgery that requires an indwelling bladder catheter after surgery.
Age Range: Four to 8 years of age are eligible for the study.
Disqualifiers
Patients who have had prior bladder surgery.
Patients who have neurologic disease that could impair bladder sensation.
Patients who are already taking antimuscarinic or antispasmodic medications.
Patients with glaucoma, any neurologic disease, dementia, impaired mentation or disorder of the central nervous system.
Trial design
Treatments tested in this trial
- Oxybutynin Transdermal Patch
- Oral Oxybutynin
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov